Peptide amino acid templated metallic nanoparticles for combating alzheimers disease
Loading...
Date
item.page.authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
The present research work involved synthesis of amino acid/peptide templated metallic nanostructures as therapeutic modalities to treat Alzheimer s disease. We synthesized levodopa (an amino acid analogue) templated gold nanoroses (GNR) and an amphipathic dipeptide, arginine dehydrophenylalanine (Rand#916;F) vesicles templated selenium nanoparticles (Rand#916;F-SeNPs) as potential anti-aggregating agents targeting the model amyloidogenic peptides. These nanoparticles were characterized by various spectroscopic and microscopic methods. The amyloid model peptides, diphenylalanine (FF) and Ac-PHF6 (VQIVYK) were initially synthesized and further these peptides were assessed for their aggregation potential utilizing microscopic (SEM and confocal microscopy) and spectroscopic (ThT) analysis. It was also observed that FF and Ac-PHF6 fibrils caused toxicity to SH-SY5Y cells in a concentration dependent way Further, the anti-amyloidogenic potential of the synthesized nanoparticles (GNR and Rand#916;F-SeNPs) was determined against amyloid model peptides as well as full length Aand#946; polypeptide. Concisely, this research work was undertaken on scientific rationale with potential outcomes. We believe that the work can form the basis for the development of effective disease-modifying therapeutic agents for AD.
newline